Who will guard the guards? Medical leadership and conflict of interest in South African healthcare

Raymond Pierre Abratt


Conflicts of interest (COI) arising from the interaction of the pharmaceutical industry with doctors have been described in an SAMJ editorial. A number of important measures to deal with COI are described in the editorial, including disclosure of COI, creating awareness of the problem, academic discussions and fostering professionalism by practitioners. A further measure that should be included to complement the above is the use of clinical protocols (standardised care guidelines), which reduce conflicts of interest and facilitate the documentation of a body of experience on which to base patient care in the future.

Author's affiliations

Raymond Pierre Abratt, Head of Clinical Governance, Independent Clinical Oncology Network, and Professor Emeritus, University of Cape Town, South Africa

Full Text

PDF (42KB)


Conflicts of interest; Pharmaceutical industry

Cite this article

South African Medical Journal 2016;106(2):129. DOI:10.7196/SAMJ.2016.v106i2.9679

Article History

Date submitted: 2015-04-05
Date published: 2016-01-11

Article Views

Abstract views: 1968
Full text views: 679

Comments on this article

*Read our policy for posting comments here